302 related articles for article (PubMed ID: 28342976)
1. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease.
de Gonzalo-Calvo D; Cenarro A; Garlaschelli K; Pellegatta F; Vilades D; Nasarre L; Camino-Lopez S; Crespo J; Carreras F; Leta R; Catapano AL; Norata GD; Civeira F; Llorente-Cortes V
J Mol Cell Cardiol; 2017 May; 106():55-67. PubMed ID: 28342976
[TBL] [Abstract][Full Text] [Related]
2. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
Escate R; Padró T; Pérez de Isla L; Fuentes F; Alonso R; Mata P; Badimon L
Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437
[TBL] [Abstract][Full Text] [Related]
4. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
[TBL] [Abstract][Full Text] [Related]
5. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.
Zhang Y; Wang Y; Zhang L; Xia L; Zheng M; Zeng Z; Liu Y; Yarovinsky T; Ostriker AC; Fan X; Weng K; Su M; Huang P; Martin KA; Hwa J; Tang WH
Circ Res; 2020 Sep; 127(7):855-873. PubMed ID: 32597702
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease.
Zietzer A; Steffen E; Niepmann S; Düsing P; Hosen MR; Liu W; Jamme P; Al-Kassou B; Goody PR; Zimmer S; Reiners KS; Pfeifer A; Böhm M; Werner N; Nickenig G; Jansen F
Cardiovasc Res; 2022 Jan; 118(1):316-333. PubMed ID: 33135066
[TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
[TBL] [Abstract][Full Text] [Related]
8. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients.
Liu W; Ling S; Sun W; Liu T; Li Y; Zhong G; Zhao D; Zhang P; Song J; Jin X; Xu Z; Song H; Li Q; Liu S; Chai M; Dai Q; He Y; Fan Z; Zhou YJ; Li Y
Sci Rep; 2015 Nov; 5():16099. PubMed ID: 26537670
[TBL] [Abstract][Full Text] [Related]
11. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.
Singh S; de Ronde MWJ; Kok MGM; Beijk MA; De Winter RJ; van der Wal AC; Sondermeijer BM; Meijers JCM; Creemers EE; Pinto-Sietsma SJ
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487772
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
[TBL] [Abstract][Full Text] [Related]
13. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1.
Li M; Liu Q; Lei J; Wang X; Chen X; Ding Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):270-276. PubMed ID: 28890348
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing.
Zhong Z; Zhong W; Zhang Q; Zhang Q; Yu Z; Wu H
J Clin Lab Anal; 2020 Jan; 34(1):e23020. PubMed ID: 31489700
[TBL] [Abstract][Full Text] [Related]
16. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
[TBL] [Abstract][Full Text] [Related]
17. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
[TBL] [Abstract][Full Text] [Related]
18. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease.
Ren J; Zhang J; Xu N; Han G; Geng Q; Song J; Li S; Zhao J; Chen H
PLoS One; 2013; 8(12):e80738. PubMed ID: 24339880
[TBL] [Abstract][Full Text] [Related]
19. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis.
de Gonzalo-Calvo D; Cenarro A; Martínez-Bujidos M; Badimon L; Bayes-Genis A; Ordonez-Llanos J; Civeira F; Llorente-Cortés V
Int J Cardiol; 2015 Dec; 201():20-9. PubMed ID: 26285183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
